WO1996025933A3 - Use of vinyl carboxylic acid compounds for the treatment or prevention of transient ischaemic attacks - Google Patents
Use of vinyl carboxylic acid compounds for the treatment or prevention of transient ischaemic attacks Download PDFInfo
- Publication number
- WO1996025933A3 WO1996025933A3 PCT/JP1996/000394 JP9600394W WO9625933A3 WO 1996025933 A3 WO1996025933 A3 WO 1996025933A3 JP 9600394 W JP9600394 W JP 9600394W WO 9625933 A3 WO9625933 A3 WO 9625933A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- prevention
- treatment
- carboxylic acid
- acid compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU47309/96A AU4730996A (en) | 1995-02-22 | 1996-02-21 | Use of vinyl carboxylic acid compounds for the treatment or prevention of transient ischaemic attacks |
EP96903205A EP0810862A2 (en) | 1995-02-22 | 1996-02-21 | Use of vinyl carboxylic acid compounds for the treatment or prevention of transient ischaemic attacks |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3396095 | 1995-02-22 | ||
JP7/33960 | 1995-02-22 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US66931696A A-371-Of-International | 1995-02-22 | 1996-07-09 | |
US09/769,440 Continuation US20010003751A1 (en) | 1995-02-22 | 2001-01-26 | Pharmaceutical composition for treating transient ischemic attack |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1996025933A2 WO1996025933A2 (en) | 1996-08-29 |
WO1996025933A3 true WO1996025933A3 (en) | 1996-10-17 |
Family
ID=12401068
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1996/000394 WO1996025933A2 (en) | 1995-02-22 | 1996-02-21 | Use of vinyl carboxylic acid compounds for the treatment or prevention of transient ischaemic attacks |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0810862A2 (en) |
AU (1) | AU4730996A (en) |
CA (1) | CA2213507A1 (en) |
WO (1) | WO1996025933A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4194095B2 (en) * | 2001-09-11 | 2008-12-10 | 旭化成ファーマ株式会社 | Pharmaceutical composition for prevention / treatment of cerebrovascular disorder and heart disease |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0098690A2 (en) * | 1982-06-14 | 1984-01-18 | Takeda Chemical Industries, Ltd. | Vinyl carboxylic acid derivatives, their production and use |
-
1996
- 1996-02-21 WO PCT/JP1996/000394 patent/WO1996025933A2/en not_active Application Discontinuation
- 1996-02-21 AU AU47309/96A patent/AU4730996A/en not_active Abandoned
- 1996-02-21 CA CA 2213507 patent/CA2213507A1/en not_active Abandoned
- 1996-02-21 EP EP96903205A patent/EP0810862A2/en not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0098690A2 (en) * | 1982-06-14 | 1984-01-18 | Takeda Chemical Industries, Ltd. | Vinyl carboxylic acid derivatives, their production and use |
Non-Patent Citations (9)
Title |
---|
AL-WATHIQUI, M. ET AL: "Cyclical carotid artery flow reduction in conscious dogs: Effect of a new thromboxane receptor antagonist", AMERICAN HEART JOURNAL, vol. 116, no. 6 pt. 1, December 1988 (1988-12-01), pages 1482 - 1487, XP000579143 * |
ARCH JPN CHIR, 55 (1). 1986. 251-259. * |
BRAIN NERVE, 1986, 38/10 (925-931), JAPAN * |
DATABASE BIOSIS BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; OKAMOTO S ET AL: "TREATMENT OF OCCLUSIVE CEREBROVASCULAR DISEASE WITH A SELECTIVE THROMBOXANE A-2 SYNTHETASE INHIBITOR", XP002010663 * |
DATABASE EMBASE ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL; IMURA Y. ET AL: "Protective effect of CV-4151 (isbogrel) on arachidonic acid-induced transient cerebral ischemia in dogs", XP002010662 * |
DATABASE EMBASE ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL; KATAYAMA Y. ET AL: "Protective effect of thromboxane Asub 2 synthetase inhibitor (trapidil) on acutely-induced cerebral ischemia", XP002010664 * |
FUJIMURA M ET AL: "Effect of Y-20811, a thromboxane synthetase inhibitor, on photochemically induced cerebral embolism in rabbits.", THROMB RES, MAY 1 1993, 70 (3) P233-44, UNITED STATES, XP000579091 * |
JAPANESE PHARMACOLOGY AND THERAPEUTICS, 1995, 23/4 (45-52), JAPAN * |
SATOH, H. ET AL: "Protective effects of KW-3635, a thromboxane A2 antagonist on arachadonic acid-induced transient cerebral ischemia in dogs", JAPANESE JOURNAL OF PHARMACOLOGY, vol. 65, no. 1, May 1994 (1994-05-01), pages 45-50, XP000578984 * |
Also Published As
Publication number | Publication date |
---|---|
WO1996025933A2 (en) | 1996-08-29 |
EP0810862A2 (en) | 1997-12-10 |
CA2213507A1 (en) | 1996-08-29 |
AU4730996A (en) | 1996-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO5280070A1 (en) | COMPOUNDS, PHARMACEUTICAL COMPOSITIONS OF INDAZOL AND METHODS TO MEASURE OR INHIBIT THE CELL PROLIFERATION | |
EA200000731A1 (en) | ALPHA-AMINOAMID DERIVATIVES, USEFUL AS ANALGETIC AGENTS | |
CA2243199A1 (en) | Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents | |
CA2073981A1 (en) | 2-arylthiazole derivatives and pharmaceutical composition thereof | |
CA2328780A1 (en) | Dihydropyrimidines | |
CA2315050A1 (en) | Aminophenoxyacetic acid derivatives and pharmaceutical composition containing thereof | |
WO2003039451A3 (en) | Thiazole pyridazinones as adenosine antagonists | |
BR0309447A (en) | Compound, agent, processes for their preparation, and for combating unwanted plant growth, and use of the compound | |
DE69505968D1 (en) | AZOLIDINDION DERIVATIVES AND THEIR USE AS ANTI-HYPERGLYCEMAS | |
EA200101077A1 (en) | COMPOSITION FOR PREVENTION OR TREATMENT OF WEAKNESS, INCLUDING A HYDROXICORIC ACID DERIVATIVE OR EXTRACT OF ANGELICAE GENERA PLANT, CONTAINING IT | |
FR2741619B1 (en) | NOVEL 2,3,5-TRIMETHYL-4-HYDROXY-ANILIDES DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION | |
KR920009394A (en) | Synergistic HIV Reverse Transcriptase Inhibitor | |
CA2067758A1 (en) | Piperidine and pyrrolidine derivatives | |
CA2357038A1 (en) | Medical compositions comprising 1,4-benzothiazepine derivatives for the treatment of atrial fibrillation | |
RU94045271A (en) | Use of 2-phenyl-3-aroylbenzothiophenes for terner's syndrome inhibition | |
CA2016665A1 (en) | Rhodanine derivatives and pharmaceutical compositions | |
IL114969A0 (en) | Carboxamide compounds | |
WO1996025933A3 (en) | Use of vinyl carboxylic acid compounds for the treatment or prevention of transient ischaemic attacks | |
EP0335979A4 (en) | Thienopyrimidine derivatives | |
MXPA02011352A (en) | Novel benzofuran derivatives. | |
ES2170804T3 (en) | DERIVATIVES OF DIHIDRO-2,3-BENZODIAZEPINA. | |
RS49832B (en) | Method for preparing alkyloxy furanone derivatives, compounds obtained by sajd method and use of sajd compounds | |
KR880008999A (en) | 3-aryl-5-alkylthio-4H-1,2,4-triazole | |
MY133207A (en) | Substituted benzolactam compaunds | |
SE9802546D0 (en) | Medicinal product and method for treatment and prevention of dyskinesia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENP | Entry into the national phase |
Ref country code: US Ref document number: 1996 669316 Date of ref document: 19960709 Kind code of ref document: A Format of ref document f/p: F |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AU AZ BB BG BR BY CA CN CZ EE FI GE HU IS KG KR KZ LK LR LT LV MD MG MK MN MX NO NZ PL RO RU SG SI SK TJ TM TR TT UA US UZ VN AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AU AZ BB BG BR BY CA CN CZ EE FI GE HU IS KG KR KZ LK LR LT LV MD MG MK MN MX NO NZ PL RO RU SG SI SK TJ TM TR TT UA US UZ VN AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1996903205 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2213507 Country of ref document: CA Ref country code: CA Ref document number: 2213507 Kind code of ref document: A Format of ref document f/p: F |
|
WWP | Wipo information: published in national office |
Ref document number: 1996903205 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1996903205 Country of ref document: EP |